Financials

  • Market Capitalization 479.78 M
  • Employee 48
  • Founded 2020
  • CEO N/A
  • Website www.evommune.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y79N887
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.53
Fiyat/satışlar oranı
8.08

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2899
KYTX
Kyverna Therapeutics, Inc. - Common Stock
8.37 USD-3.13%+0.60%+15.61%+133.15%517.63 M USD
2937
EDIT
Editas Medicine, Inc. - Common Stock
3.16 USD-4.24%+0.64%+21.54%+25.40%485.31 M USD
2944
PRTA
Prothena Corporation plc - Ordinary Shares
9.33 USD+2.64%-1.37%+9.76%+14.20%478.97 M USD
2954
CCCC
C4 Therapeutics, Inc. - Common Stock
3.85 USD-6.10%-3.02%+9.07%+49.81%473.65 M USD